from:
http://www.mercola.com/2001/jul/11/vitamin_c_cancer.htm

They Say That Vitamin Can Increase the Risk of Cancer 
Oh yes? And who's 'they'? 

Steven Ransom 

"Vitamin C Cancer Fear. High doses of Vitamin C could
increase the risk of cancer, scientists warn today…." 

So begins the 15th June 2001 UK Daily Mail front-page
report, outlining the work of Dr Ian Blair, resident
researcher at the University of Pennsylvania Pharmacology
Unit. The Mail headline appears to be in direct conflict
with Dr Blair's own statement:  

"Absolutely, for God's sake, don't say Vitamin C causes
cancer." (Yahoo News, Thursday June 14th, 2001) But of
course, The Mail and others have shamelessly done exactly
that. To the less discerning reader, the story raises
worrisome questions as to the wisdom of high-level Vitamin C
supplementation. If these worldwide headlines have served
any useful purpose at all, it has been to confirm the
moral/intellectual void currently reigning in today's mass
media 'news' departments.  

At a more fundamental level, why is Dr Blair conducting
tests on the efficacy of Vitamin C at all? We are about to
discover that certain parties have a very definite interest
in casting aspersions upon Vitamin C. Yet again, we are
being taught what to think about a certain subject, but not
how. To our knowledge, the information you are about to read
has not been included in any of the latest, and now
worldwide 'Vitamin C Cancer Scare' headlines generated by Dr
Blair's findings.  

A Golden Rule 

Dr Blair postulates that high consumption of Vitamin C (a
most beneficial adjunct in non-toxic cancer recovery
treatment) might actually cause human tissue degeneration,
which in turn could lead to a heightened risk of contracting
cancer.  

And it is here that we arrive at our first golden rule: when
it comes to assessing the veracity of any scientific claim,
we must always read between the lines - we must search for
what the report does not say. We must especially be on the
look-out for that hoary old chestnut, otherwise known as
vested interests. A University of Manchester research
methodology handbook contains the following valuable advice:

"Science and research must be studied in the context of all
the interested parties involved. The questions centre on
determining the relative weight of the various allies in the
'fact-creating' process - e.g. funding bodies, businesses,
departments of state, professions and other scientists. 

In analysing scientific debates, one should always ask what
social, institutional, political and philosophical interests
lie behind often apparently 'neutral' and 'technical'
knowledge claims." (University of Manchester Institute of
Science & Technology (UMIST) research methodology course
handout, 1994) (emphasis mine) 

On the matter of the 'fact creation' process, renowned
author John Le Carre recently stated:  

"Big Pharma [the industry in general] is engaged in the
deliberate seduction of the medical profession, country by
country, worldwide. It is spending a fortune on influencing,
hiring and purchasing academic judgment to a point where, in
a few years' time, if Big Pharma continues unchecked on its
present happy path, unbought medical opinion will be hard to
find." (The Nation, New York, Interview with John Le Carre,
9th April 2001) 

Bought? 

With the above in mind, lets put Dr Blair's University of
Pennsylvania under the spotlight and see what encouragement
Dr Blair might have had in taking his extraordinary position
and apparently misquoted position against Vitamin C.  

We must ask the following questions: what Big Pharma
influences might there be supporting the University of
Pennsylvania Cancer Center (UPCC) and its mother ship, the
University of Pennsylvania Health Service? What is the
relative weight of the funding bodies? If industry
sponsorship is taking place, are UPHS personnel free to
exercise unbiased critical thinking? Or are there grounds to
suspect that UPHS been 'bought' - that somewhere along the
line, vested interests have 'purchased academic judgment'?  

Before tackling the Vitamin C issue itself, the following
UPHS general statistics are very revealing. 

Certain Alliances 

In May 2000, Dr Ian Blair's employers at UPCC received a $26
million, five year Core Grant from the National Cancer
Institute (NCI) - the largest and most influential
conventional cancer treatment institution in the world. In
fact, UPCC has been continuously funded by the NCI Core
Grant mechanism since the grant was created by the National
Cancer Act in the early 1970's.  

Currently, UPCC is awash with more than $100 million in
cancer research funding:  

$37 million is from the National Cancer Institute; $43
million from closely affiliated organisations, such as the
National Institutes of Health, the organisation which
actually funded Dr Blair's Vitamin C research; another $12
million from foundational support such as the American
Cancer Society and the Leukaemia Society; and between $8 and
$10 million from various pharmaceutical companies. Earlier,
in June of 1999, UPCC received a $4.5 million gift from the
William H. Gates Foundation to research conventional
treatments for non-Hodgkin's lymphoma.  

Aside from the Bill and Melinda Gates connection, OncoLink,
the University of Pennsylvania Cancer Center, [28] is
sponsored very generously by the following corporations:
Amgen, the world's largest independent biotechnology
company; Aventis, Ortho Biotech, Inc., Varian, Inc., Janssen
Pharmaceutica, AstraZeneca, Pharmacia Upjohn and Pfizer.
These corporations are very big indeed, and their names
represent no mean sponsorship committee. 

More Alliances 

In March 2001, UPHS announced a strategic alliance with
Siemens Medical Systems, Inc. Under the terms of the
purchasing agreement, UPHS will make an initial discounted
purchase of cardiology, radiology and radiation oncology
equipment from Siemens, who will also service and maintain
the biomedical equipment already in place at designated UPHS
sites over the life of the agreement.  

In the year 2000, Siemens Medical Solutions, based in
Iselin, New Jersey, reported new orders of $5.65 billion,
sales of $5.44 billion and employs 27,000 worldwide. "This
is the kind of alliance that will be critical in our
continuing financial recovery and to assure our position as
a leading national health system," said Robert D. Martin,
Ph.D., Chief Executive Officer of UPHS.  

A good relationship with Siemens may well be critical to
UPHS' financial recovery, but does this kind of dependent
alliance foster the aforementioned necessary climate for
critical thinking? What if there are privately held UPHS
reservations over the Siemens equipment, methodology or
ethos? Who will break rank first? Will anyone? What kind of
commercially gagged framework are the UPHS staff now locked
into with Siemens?  

Yet More Corporate Alliances 

On April 26, 2001, UPCC announced a business partnership
with Integral PET Associates, the nation's leading operator
of fixed-site Positron Emission Tomography (PET) cancer
scanners. A patient receiving a PET scan today is injected
with a radiopharmaceutical, such as flurodeoxyglucose (FDG),
about 45 minutes before the scan, which takes about two
hours.  

The radiopharmaceutical tracer emits signals which are then
picked up by the PET scanner. A computer reassembles the
signals into recognisable images to determine if a cancer
has spread, if a particular treatment is effective, or if a
patient is disease-free. IPA will now be seeking to supply
major hospitals throughout Pennsylvania with this very
expensive equipment. Installing and operating a PET scanner
typically costs around $1,600,000 in up-front capital costs,
plus an additional $800,000 in yearly staff and operational
costs.  
A short visit to the UPHS website at
www.med.upenn.edu will not only confirm all of the above
information, but will also confirm that these alliances
represent only a small percentage of the long-standing
conventional 'friendships' UPHS has fostered with Big Pharma
over the years. Given the strictly conventional source of
sponsorship monies received at UPHS, what chance will the
following statements have of being 'allowed' to feature on
the UPHS cancer information page? 

"If I contracted cancer, I would never go to a standard
cancer treatment centre. Cancer victims who live far from
such centres have a chance." Professor Charles Mathe, French
cancer specialist  

"...as a chemist trained to interpret data, it is
incomprehensible to me that physicians can ignore the clear
evidence that chemotherapy does much, much more harm than
good." - Alan C Nixon, PhD, former president of the American
Chemical Society  

"Doctors are too busy to dig into the statistics of cancer
treatments, they assume that what they are taught at school
or what is demonstrated in the pages of briefing journals is
the best treatment. They cannot afford to suspect that these
treatments are only the best for the pharmaceutical
companies that influence their 'institutions of higher
learning'." Paul Winter, The Cancell Home Page. 

"To the cancer establishment, a cancer patient is a profit
center. The actual clinical and scientific evidence does not
support the claims of the cancer industry. Conventional
cancer treatments are in place as the law of the land
because they pay, not heal, the best. Decades of the
politics-of-cancer-as-usual have kept you from knowing this,
and will continue to do so unless you wake up to this
reality." - Lee Cowden MD 

"Almost every patient treated with IL2 (a current
conventional cancer treatment) suffered fever, malaise,
nausea or vomiting, diarrhoea, sharp drops in blood
pressure, skin rashes, breathing difficulties, liver
abnormalities and irregularities in blood chemistry.
Rosenberg himself details a number of horrifying case
histories, and one in particular where the administration of
IL2 had precipitated amongst other things, vomiting, swollen
joints, lung fluid and 'vascular leak syndrome' where blood
would ooze through the vessel walls and collect under the
skin." Steven Rosenberg, The Transformed Cell, 1992. (IL2 is
still used today.) 

"Dr Linus Pauling, often known as the 'Father of Vitamin C'
and twice awarded the Nobel Prize, declared that large
intakes of up to 10g of the vitamin each day aids
anti-cancer activity within the body. Pauling was largely
derided for making these declarations, but today, large
doses of Vitamin C are used by many practitioners for cancer
patients in nutritional therapy, who believe Pauling was
right and that the popular nutrient is indispensable to the
body in its fight to regain health from cancer." Phillip
Day, Cancer, Why We're Still Dying to Know The Truth,
Credence Publications, 2001.  

"Do not let either the medical authorities or the
politicians mislead you. Find out what the facts are, and
make your own decisions about how to live a happy life and
how to work for a better world." Linus Pauling
http://www.cforyourself.com 

The above remarks are representative of a vast library of
well-sourced contrary information which sensibly questions
the validity and efficacy of conventional cancer treatments
based on a huge amount of clinical research and data.
Naturally, with all these expensive and patented treatments
available to fight cancer, the cancer rates should be going
down. They are not. They are increasing.  

Staggering Amounts 

UPHS is totally locked into the conventional cancer
framework - a framework which today, rightly stands accused
of achieving no measurable success at all in its approach to
the treatment of cancer, immense success in causing
widespread, unnecessary death through its application of
lethal and highly toxic pharma-radiation treatments, and
even greater success in rewarding itself absolutely
staggering amounts of money in the whole grisly process.
That these cancer corporations have become incredibly
wealthy through their 'chemo 'til we drop' approach is a
fact which Messrs Siemens, Zeneca, Upjohn, Glaxo, Rhone
Poulenc cannot deny.  

Common Sense 

Pauling was right. We have been seriously misled. Taking the
Siemens $multi-million technology as an example, it may well
detect certain forms of cancer, but upon detecting it, what
then happens? Quite simply, a bewildered, obedient, grateful
and unsuspecting cancer sufferer is immediately directed
towards the door marked 'iatrogenic (doctor-induced) illness
and probable death.'  

Closer examination of today's orthodox cancer treatments
clearly reveals that the conventional path is fraught with
toxic danger. But the CEO of UPHS has made it quite clear
that 'the Siemens alliance [one of so many] is critical to
the financial security of UPHS'.  

This is why we will hear no publicly dissenting voices from
UPHS as to the horrific realities associated with 20th and
21st Century conventional cancer treatments. The corporate
big boys' riches must continue to flow…. and a handsome
proportion of it into the coffers of the very dependent
UPHS, of course, 'to assist in their financial recovery'.  

So Why the Slur on Vitamin C? 

As has already been stated, conventional cancer treatment
represents a $multi-billion a year industry. These vast
profits are fiercely protected by the industry giants. But
their treatments in no way address the underlying causes of
cancer. Cancer is a nutritional/toxic/environmental
condition, which, in a great number of instances, can be
successfully reversed through the application of a sound
nutritional approach and common-sense lifestyle changes.
Linus Pauling, dubbed the father of Vitamin C, sensibly
promoted the benefits of consuming high doses Vitamin C in
the prevention of and battle against cancer. 

Half-Truths and Lies 

So why aren't we hearing about these natural treatment
successes? Why aren't they being heralded across the world?
The answer is money. Despite the multitudinous successes in
cancer regression through nutrition, and through extensive
application of vital elements such as Vitamin C, Vitamin
B17, pancreatic enzymes and other co-factors, Big Pharma is
doing all it can to silence these success stories. To have
it become widely known that cancer can be successfully
treated without toxic and profitable pharmaceuticals would
be catastrophic for its business.  

Who would continue to purchase these products? What would
the Siemens, Glaxo and Upjohn shareholders have to say about
that? To their shame, vested interests are keeping
well-proven, non-toxic cancer treatments from the public
domain. This is why, under 'cancer treatments' the UPHS
website says this of vitamin B17:
http://cancer.med.upenn.edu/pdq_html/6/engl/600093.html  

"Several patients displayed symptoms of cyanide poisoning,
including muscle weakness and impaired reflexes, or had
life-threatening levels of cyanide in their blood. (Laetrile
can release cyanide, which is a highly toxic chemical.) The
researchers concluded that Laetrile is not effective as a
cancer treatment and is harmful in some cases." 

But now read this contrary extract from a radio talk show,
featured in Phillip Day's Cancer, Why We Are Still Dying To
Know The Truth: 

Radio host Laurie Lee: "So this is verified, that laetrile
[B17] can have this positive effect?" 

Dr Ralph Moss: "We were finding this and yet, we in Public
Affairs were told to issue statements to the exact opposite
of what we were finding scientifically."  

At the time, Ralph Moss was former Assistant Director of
Public Relations at Memorial Sloan Kettering, NY, a leading
American conventional cancer research facility.  

Of course Laetrile, or Vitamin B17, is not approved by the
FDA, but not because it isn't beneficial - it is, as the
links provided at the bottom of this report will
demonstrate. No, Vitamin B17 has not been approved by the
FDA simply because the FDA have been leaned on. That's the
way it goes in the self-preserving, self-serving,
conventional cancer business.  

To put it bluntly, biddable FDA officials are only a phone
call and a golfing lunch away from the NCI and the NIH. A
classic example of these conflicts of interests and double
standards can be appreciated when one learns that sodium
fluoride is also not approved by the FDA due to its
toxicity, and yet drug giant Proctor and Gamble and others
can market the stuff in their toothpastes with complete
impunity.  

The UPHS statement on Laetrile is a fabrication. Such is the
wealth of evidence overturning the conventional stance on
Laetrile and Vitamin C, that one can only assume the UPHS
statement falls into the following category:  

False Scientific Research 'Endangering the Public',
Independent 

News, 13.12. 2000 Doctors are fabricating research results
to win grants and advance their careers, but the medical
establishment is failing to protect the public from the
menace of these scientific frauds, a committee of medical
editors said yesterday. Eighty cases of fraudulent research
have been detected in the past four years, and 30 have been
investigated in the past year. In some cases, institutions
have covered up wrongdoing to protect reputations…. 

The Nub of It 

In an effort to subvert this mass-awakening to the horrors
of conventional cancer treatments, a devious attack on all
genuinely beneficial, natural (and therefore un-patentable)
anti-cancer products is now being waged by a rather worried
conventional cancer establishment The ever-so-gentle slur on
our most vital of vitamins, namely Vitamin C, will soon be
extended to a wide range of essential minerals and vitamins.
 

This is just the beginning of the subtle, but concerted
attack. The latest conventional legislation surrounding the
codifying and banning of efficacious natural treatments is
being instituted, purely because there is no money in these
natural treatments for Big Pharma. It is profit before human
health, but couched in respectable-looking, 'sciency'
reports. And this veneer of respectability is fooling the
unsuspecting minions lower down the UPHS research chain it
seems. 

Naive 

The two UPHS officials I spoke to regarding Dr Blair's
Vitamin C report were extremely pleasant, open and helpful
and displayed no intention to supply misleading information.
But both persons were entirely locked into their superiors'
way of thinking. Media Relations officer Olivia Fermano was
curious as to my interest into who funded the Vitamin C
report. When I pointed out that if Dr Blair's funding could
be traced to a pharmaceutical company producing conventional
cancer treatments, then the results would have to be very
seriously questioned, Ms Fermano was genuinely supportive.  

"My goodness! That is a good question. I will be right back
to you." Her word-for-word courteous reply, some two minutes
later was as follows: "You had me genuinely worried for a
few minutes there, sir. But I am pleased to tell you that
our funding came directly from the National Institutes for
Health itself. I am so relieved." Ho Hum. 

Similarly, Dr Garret Fitzgerald, chair of UPHS Centre for
Cancer Pharmacy Department stated: "The evidence supporting
Vitamin C as a useful adjunct in cancer treatment ranges
from scant to non-existent. Linus Pauling's work was framed
around a tenuous hypothesis only."  

Whilst the courtesy displayed by Ms Fermano and Dr
Fitzgerald is commendable, their naivety is the result of
them both working in a commercially cocooned workplace,
purposefully insulated from the many success stories
attributed to non-toxic, metabolic cancer treatments, and
from the amazing health benefits accrued from consuming a
lot more Vitamin C than the FDA's recommended daily intake
of a miserable 60 mg - barely enough to keep one out of rags
and scurvy. 

Long live Vitamin C and let's have even more of it! For a
more in-depth study of the conventional cancer industry, and
of the very good news concerning alternative cancer
treatments, readers are encouraged to visit www.credence.org
and take the cancer tour. 

Steven Ransom www.whatareweswallowing.com  

and from July 2001 Campaign for Truth in Medicine at
www.campaignfortruth.com  

--------------------------------------------------------------------------------

DR. MERCOLA'S COMMENT: 

This is a terrific followup to the article that I posted on
vitamin C a few weeks ago. It reviews some of the politics
involved with this issue.  

Related Articles: 

Does Vitamin C Really Damage Your DNA? 

 


--
The silver-list is a moderated forum for discussion of colloidal silver.

To join or quit silver-list or silver-digest send an e-mail message to: 
[email protected]  -or-  [email protected]
with the word subscribe or unsubscribe in the SUBJECT line.

To post, address your message to: [email protected]
Silver-list archive: http://escribe.com/health/thesilverlist/index.html
List maintainer: Mike Devour <[email protected]>